The rise of Sildenafil initially drove a surge for the drug industry, but recent developments present a murky picture for shareholders. Generic alternatives are eroding profits, and ongoing patent challenges add more https://ihannaspfi906302.bloggazza.com/39902280/viagra-and-pharma-a-risky-play